These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A cautionary note on design implications when the primary analysis is a stratified analysis of a binary endpoint. Chuang-Stein C. Biom J; 2006 Dec; 48(6):978-83. PubMed ID: 17240655 [Abstract] [Full Text] [Related]
4. The design and implementation of a randomized controlled trial of a risk reduction and human immunodeficiency virus prevention videogame intervention in minority adolescents: PlayForward: Elm City Stories. Fiellin LE, Kyriakides TC, Hieftje KD, Pendergrass TM, Duncan LR, Dziura JD, Sawyer BG, Fiellin DA. Clin Trials; 2016 Aug; 13(4):400-8. PubMed ID: 27013483 [Abstract] [Full Text] [Related]
5. Risks in the use of an unblinded-control group. Skoler S, Govender S, Altini L, Ahmed K, Waldron D, Myer L, Lahteenmaki P. J Infect Dis; 2005 Apr 15; 191(8):1378-9; author reply 1379-80. PubMed ID: 15776387 [No Abstract] [Full Text] [Related]
6. Control groups in microbicide trials: in defense of orthodoxy. Stein ZA, Susser MW. J Infect Dis; 2005 Apr 15; 191(8):1377-8; author reply 1379-80, 1380-1. PubMed ID: 15776386 [No Abstract] [Full Text] [Related]
7. Making sense of quality-of-life data. Guyatt GH. Med Care; 2000 Sep 15; 38(9 Suppl):II175-9. PubMed ID: 10982104 [No Abstract] [Full Text] [Related]
8. Adaptive randomization for multiarm comparative clinical trials based on joint efficacy/toxicity outcomes. Ji Y, Bekele BN. Biometrics; 2009 Sep 15; 65(3):876-84. PubMed ID: 19173694 [Abstract] [Full Text] [Related]
14. A STD/HIV prevention trial among adolescents in managed care. Boekeloo BO, Schamus LA, Simmens SJ, Cheng TL, O'Connor K, D'Angelo LJ. Pediatrics; 1999 Jan 15; 103(1):107-15. PubMed ID: 9917447 [Abstract] [Full Text] [Related]
15. Design and analysis issues in split mouth clinical trials. Hujoel PP. Community Dent Oral Epidemiol; 1998 Apr 15; 26(2):85-6. PubMed ID: 9645400 [No Abstract] [Full Text] [Related]
16. Design and analysis of non-inferiority mortality trials in oncology. Carroll K, Milsted B, Lewis JA. Stat Med; 2004 Sep 15; 23(17):2771-4; author reply 2774-8. PubMed ID: 15316946 [No Abstract] [Full Text] [Related]
17. Comments on a commentary: statistical evaluation of split mouth caries trials. Vaeth M, Poulsen S. Community Dent Oral Epidemiol; 1998 Apr 15; 26(2):80-3; discussion 84. PubMed ID: 9645399 [Abstract] [Full Text] [Related]
18. Long-term effects of a middle school- and high school-based human immunodeficiency virus sexual risk prevention intervention. Siegel DM, Aten MJ, Enaharo M. Arch Pediatr Adolesc Med; 2001 Oct 15; 155(10):1117-26. PubMed ID: 11576006 [Abstract] [Full Text] [Related]
19. Sham-Controlled Trials for Coronary Interventions: Ethically Acceptable and Ethically Important. Dickert NW, Miller FG. J Am Coll Cardiol; 2018 Jan 02; 71(1):95-97. PubMed ID: 29301633 [No Abstract] [Full Text] [Related]
20. Statistics and the relationship of clinical research to clinical practice. Khuder SA, Kahaleh B. J Rheumatol; 2009 Feb 02; 36(2):219-20. PubMed ID: 19208555 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]